Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer.
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer. N Engl J Med. 2020 06 04; 382(23):2187-2196.
View in:
PubMed
subject areas
Adenocarcinoma
Administration, Oral
Aged
Aged, 80 and over
Antineoplastic Agents, Hormonal
Cardiovascular Diseases
Gonadotropin-Releasing Hormone
Humans
Injections, Subcutaneous
Leuprolide
Male
Middle Aged
Phenylurea Compounds
Prostatic Neoplasms
Pyrimidinones
Testosterone
authors with profiles
Michael S Cookson